EUVIMED · CrossrefJournal
Journal of Clinical Psychopharmacology
ISSN 0271-0749 · Ovid Technologies (Wolters Kluwer Health)
Latest articles
Somatic Symptom Disorder Improved With Lamotrigine
Concurrent Urticaria/Angioedema and Acute Accommodation Dysfunction With Visual Acuity Loss Associated With Oral Methylphenidate in a Child With ADHD
Probable Vortioxetine-Associated Bruxism: First Reported Case
Lithium-Associated Symptomatic Sinus Bradycardia Presenting as Presyncope
Risperidone-Associated Massive Asymptomatic Creatine Kinase Elevation in a 15-Year-Old Girl
New-Onset Seizure Associated With Low-Dose Duloxetine Monotherapy
Efficacy and Safety of Brexpiprazole in Japanese Patients With Schizophrenia and Comorbid Social Anxiety Symptoms
Reply to “Caution Needed Regarding Conclusions of Meta-Analysis of Coenzyme Q10 as Treatment for Depressive Symptoms”
Challenges of Recruiting Children and Adolescents Into a Randomized Controlled Risperidone Discontinuation Trial
N-Acetylcysteine for Clozapine-Associated Sialorrhea
Six-Monthly Formulation of Paliperidone Palmitate in Delusional Disorder
Persistent Hiccups Resolve After Duloxetine
Antipsychotic Doses in Patients With Tardive Dyskinesia Who Received Valbenazine
Imipramine
Clozapine-Induced Acute Interstitial Nephritis
Adult Misuse of ADHD Stimulant Medication in the United States
Pregnancy Outcomes After First-Trimester Exposure to Vortioxetine
Antibiotic-Associated Psychosis in Children and Adolescents
Tirzepatide-Induced Weight Loss and Exacerbation of Bipolar Disorder With Clozapine Treatment
Rapid Reinitiation of Clozapine After Recent Discontinuation
The Antidepressant Effects of the mGlu2/3 Receptor Antagonist TS-161 in Treatment-Resistant Depression
GLP-1 Receptor Agonists, Lithium, and the Kidneys
Sertraline-Associated Anisocoria in a Young Adult
Kratom Is an Opioid
Question
Positive Rechallenge of Extended-Release Methylphenidate–Associated Nocturnal Enuresis in a Child With ADHD
Serum Lithium After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment
Caution Needed Regarding Conclusions of Meta-analysis on Coenzyme Q10 as Treatment for Depressive Symptoms
Lithium Concentrations After Initiation or Discontinuation of SGLT2 Inhibitors in Psychiatric Inpatients
An Open-Label, Randomized, Active Controlled Trial Evaluating Sublingual Dexmedetomidine for Moderate to Severe Agitation in Inpatients With Schizophrenia or Bipolar Disorder
Volumes
2026 · 1552025 · 1462024 · 1612023 · 1492022 · 1452021 · 1722020 · 1622019 · 1752018 · 1672017 · 1952016 · 1842015 · 1922014 · 2172013 · 1952012 · 2092011 · 1952010 · 2022009 · 1742008 · 2092007 · 2182006 · 1772005 · 1682004 · 1652003 · 1642002 · 1432001 · 1512000 · 1701999 · 1381998 · 1321997 · 1571996 · 1461995 · 1371994 · 1901993 · 1901992 · 2091991 · 1611990 · 2041989 · 1971988 · 2191987 · 210
EUVIMED